The activation of FXR showed beneficial effects on various metabolic diseases, including fatty liver diseases, type 2 diabetes, dyslipidemia, and obesity [5,7,9,10]. This evidence concerns the gene NR1H4 and obesity due to melanocortin 4 receptor deficiency.